A fatal case of Ecthyma Gangrenosum in a critically ill and immunocompromised patient.
J Infect Dev Ctries
; 17(11): 1654-1657, 2023 11 30.
Article
em En
| MEDLINE
| ID: mdl-38064400
ABSTRACT
INTRODUCTION:
This brief picture-oriented case report focuses on typical skin lesions in a patient who developed Ecthyma gangrenosum and pseudomonal sepsis after extensive immunosuppressive therapy for Pemphigus vulgaris. CASE PRESENTATION The patient was immunosuppressed with high doses of glucocorticoids and azathioprine; the follow-up after the treatment was not carried out well due to the pandemic conditions and because the patient herself got a Covid infection, which resulted in the development of pseudomonal sepsis and Ecthyma gangrenosum. The outcome was fatal despite extensive broad-spectrum antibiotic therapy, plasmapheresis, and intravenous immunoglobulins.CONCLUSIONS:
Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired infections, especially in critically ill and immunocompromised patients, because of multi-drug resistance in the first place.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções por Pseudomonas
/
Sepse
/
Ectima
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article